You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

开拓药业(09939.HK)与康宁杰瑞制药(09966.HK)合作进行产品临床研究

阿思达克 07-31 08:36
开拓药业(09939.HK)公布，与康宁杰瑞制药(09966.HK)达成合作，共同推进ALK-1单克隆抗体GT90001联合重组人源化PD-L1/CTLA-4双特异性抗体KN046治疗肝细胞癌等肿瘤的临床研究。

根据协定，开拓药业与康宁杰瑞制药将成立联合开发委员会并共同出资，就组合产品用於治疗肝细胞癌及双方共同确定的其他适应症的临床前研究、临床试验申请、临床试验及注册等环节进行合作。

Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.